Skip to main content
Signal8
Skerjanec Simona profile photo

Simona Skerjanec

CIK: 0002022163

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

IMMUNIC, INC. logo
IMUX

IMMUNIC, INC.

Director
Atrium Therapeutics, Inc. logo
RNA

Atrium Therapeutics, Inc.

Director
Avidity Biosciences, Inc. logo
RNAM

Avidity Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • IMMUNIC, INC. logo
    IMUX

    IMMUNIC, INC.

    Jul 5, 2026
    Award(A)

    Stock Option

    Direct
    25.4K shares-
  • IMMUNIC, INC. logo
    IMUX

    IMMUNIC, INC.

    Jun 29, 2026
    Award(A)

    Stock Option

    Direct
    25.4K shares-
  • Atrium Therapeutics, Inc. logo
    RNA

    Atrium Therapeutics, Inc.

    Feb 27, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    20K shares-
  • Avidity Biosciences, Inc. logo
    RNAM

    Avidity Biosciences, Inc.

    Feb 27, 2026
    Disposition(D)
    Direct
    6.7K shares-
  • Avidity Biosciences, Inc. logo
    RNA

    Avidity Biosciences, Inc.

    Jun 10, 2025
    Award(A)
    Direct
    6.7K shares-
  • IMMUNIC, INC. logo
    IMUX

    IMMUNIC, INC.

    Jun 5, 2025
    Award(A)

    Stock Option

    Direct
    150K shares-

1-6 of 6

About Skerjanec Simona

Skerjanec Simona (SEC CIK 0002022163) files insider reports with the SEC as Director of IMMUNIC, INC. (IMUX), Director of Atrium Therapeutics, Inc. (RNA) and Director of Avidity Biosciences, Inc. (RNAM).

Signal8 holds 7 ownership filings by Skerjanec Simona (1 Form 3, 6 Form 4), filed between Jun 9, 2025 and Jul 7, 2026. Those filings report 6 transactions, from Jun 5, 2025 to Jul 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Skerjanec Simona's filings is in NEW YORK, NY.

Recent filings by Skerjanec Simona

  • Jul 5, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
  • Jun 29, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
  • Feb 27, 2026: Grant or award of RNA derivative securities (Form 4, code A).
  • Feb 27, 2026: Disposition to issuer transaction of RNAM shares (Form 4, code D).
  • Jun 10, 2025: Grant or award of RNA shares (Form 4, code A).

Other insiders filing for IMMUNIC, INC. (IMUX)

How to read Form 4 transaction codes